Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Dec 5;19(12):e0314348.
doi: 10.1371/journal.pone.0314348. eCollection 2024.

Effects of triple semicircular canal plugging on hearing in patients with Meniere's disease: A systematic review and meta-analysis

Jia Quan Zhu  1 , Li Li Kang  2 , Xiao Dong Wen  3 , Jing Xiao  3 , Yu Jie Li  3 , Rong Li  3 , Hong Jun Liu  4 , Hong Juan Wang  3 , Fu Yu Qiao  3 , Dongbao Yang  3 , Bin Xiang  3
Affiliations
Meta-Analysis

Effects of triple semicircular canal plugging on hearing in patients with Meniere's disease: A systematic review and meta-analysis

Jia Quan Zhu et al. PLoS One. .

Abstract

Introduction: Triple semicircular canal plugging is effective in controlling vertigo in patients with Meniere's disease, however, whether the rate of causing hearing loss during treatment is still not uniform. This study aimed to evaluate the effects of Triple semicircular canal plugging (TSCP) on hearing in Meniere's disease (MD) patients.

Methods: Databases Reviewed were PubMed, EMBASE, Scopus, Clinical Trials, Web of Science, Cochrane Library, CNKI, Wanfang, and VIP. The study reported on the duration, follow-up time, hearing loss, and vertigo control outcomes in MD patients evaluated by TSCP. Stata 17 software was used for data analysis and assessing the risk of bias.

Results: This meta-analysis included 367 MD patients from 7 studies. TSCP efficiently alleviated vertigo with a rate of 99% (95% CI: 0.97, 1.00) and had a hearing loss rate of 22% (95% CI: 0.16, 0.28). Subgroup analysis revealed that for hearing loss, the proportion of patients with disease duration more than or less than 12 months was 14% (95% CI: 0.05, 0.26) and 24% (95% CI: 0.19, 0.29), respectively. For vertigo control, the rates were 100% (95% CI: 0.96, 1.00) and 99% (95% CI: 0.97, 1.00), respectively. For hearing loss, the follow-up time of MD patients more than or less than 24 months was 20% (95% CI: 0.07, 0.38) and 23% (95% CI: 0.18, 0.29), respectively. For vertigo control, the rates were 99% (95% CI: 0.95, 1.00) and 99% (95% CI: 0.97, 1.00), respectively. The duration of the disease and follow-up time had no significant impact on hearing loss and vertigo control rates.

Conclusions: TSCP was efficient for vertigo control but with a risk of hearing loss. It could be used as a surgical method for hearing preservation in advanced MD patients.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Research selection procedure based on the PRISMA flowchart.
Fig 2
Fig 2. Rates of hearing loss and vertigo control.
(A) presents the rate of hearing loss after Triple Semicircular Canal Plugging (TSCP) treatment among patients with Meniere’s disease (MD), derived from a meta-analysis of included studies. (B) It depicts the vertigo control rate after TSCP treatment among MD patients, also based on a meta-analysis.
Fig 3
Fig 3. Subgroup analysis.
(A) displays the subgroup analysis of hearing loss rates based on follow-up time after TSCP treatment. (B) presents the subgroup analysis of hearing loss rates according to the duration of disease in MD patients. (C) illustrates the subgroup analysis of vertigo control rates based on follow-up time after TSCP treatment. (D) depicts the subgroup analysis of vertigo control rates according to the duration of disease in MD patients.
See this image and copyright information in PMC

References

    1. Perez-Carpena P, Lopez-Escamez JA. Current understanding and clinical management of Meniere’s disease: a systematic review. Semin Neurol 2019;40:38–50. doi: 10.1055/s-0039-3402065 - DOI - PubMed
    1. Gibson WPR. Meniere’s Disease. Adv Otorhinolaryngol 2019;82:77–86. doi: 10.1159/000490274 - DOI - PubMed
    1. Foster CA, Breeze RE. Endolymphatic hydrops in Meniere’s disease: cause, consequence, or epiphenomenon? Otol Neurotol 2013;34:1210–1214. doi: 10.1097/MAO.0b013e31829e83df - DOI - PubMed
    1. Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V. International consensus (ICON) on treatment of Ménière’s disease. Eur Ann Otorhinolaryngol Head Neck Dis 2018;135:S29–S32. doi: 10.1016/j.anorl.2017.12.006 - DOI - PubMed
    1. Qinming Cai, Yangming Leng, Yu Sun. Semicircular canal occlusion. Journal of clinical otolaryngology head and neck surgery, 2024, 38 (2): 122–126. doi: 10.13201/j.issn.2096-7993.2024.02.008 - DOI - PMC - PubMed